NHS faces ‘bleak’ funding prospects
July 29, 2009NHS, healthcare
The prospects for future funding of the NHS "now look bleak", according to a new report by the King's Fund …
Genzyme cuts forecasts on production problems
July 29, 2009Manufacturing and Production, Sales and Marketing Genzyme
The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …
WorldEvents opens office in Switzerland
July 28, 2009Business Services WorldEvents
Event management agency WorldEvents has opened a new office in Switzerland. It has recruited Uwe Bornemann, an experienced event professional, …
Merck and Schering-Plough propose shareholder settlement
July 28, 2009Sales and Marketing MA, Merck
Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …
GSK to co-market Amgen’s osteoporosis drug in Europe
July 28, 2009Sales and Marketing Amgen, Deals, GSK
GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …
Contract research news in brief
July 28, 2009Research and Development CRO
The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …
Canada’s biotech challenge
July 27, 2009Research and Development Canada, Transition Therapeutics, biotech, funding
The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
AAIPharma sells development services unit
July 27, 2009Manufacturing and Production, Research and Development AAI Pharma
US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …
Manufacturing news in brief
July 27, 2009Manufacturing and Production GSK
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Takeda, Merrion Pharma, Cambridge Major, Dendreon and GlaxoSmithKline, …
Sales strategies for a changing environment
July 24, 2009Sales and Marketing market access, sales, strategy
Over the last two years the UK pharma industry's established product sales strategies have begun to change. The industry's primary …
Nextpharma gets nod for Belgian manufacturing unit
July 24, 2009Manufacturing and Production Next Pharma
UK contract development and manufacturing company NextPharma has won a preliminary green light from the authorities in Belgium for its …
Merck makes progress on vaccines supply issues
July 24, 2009Manufacturing and Production Merck
Merck & Co's new manufacturing facility in Durham, North Carolina, is on schedule to start production of vaccines in the …
BMS buys Medarex for $2.1 billion
July 24, 2009Research and Development, Sales and Marketing BMS, MA, Medarex
Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …
Generic losses outweigh pandemic pluses for GSK
July 23, 2009Sales and Marketing GSK
GlaxoSmithKline has reported a 2% fall in sales for the second quarter as growing generic competition in the US bites. …
Lupus drug shows surprise phase III success
July 23, 2009Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus
GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …
Profits slump at Lonza as business is realigned
July 23, 2009Manufacturing and Production Lonza
Swiss chemical and contract manufacturing group Lonza saw a slump in sales and profits in the first half of the …
Kennedy calls for overhaul of NICE processes
July 23, 2009Research and Development, Sales and Marketing NICE, hta
NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
